Senolytics for Secondary Progressive MS

Clinical trial NCT07270120 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07270120
Sponsor: Ohio State University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS) Secondary Progressive

Start date: 2026-01-15
Primary completion: 2027-01-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.